|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 336 out of 336 for Abcc1

<< First    < Previous  |  Next >    Last >>
0.029s
Type Details Score
Protein
Organism: Mus musculus/domesticus
Length: 796  
Fragment?: true
•
•
•
•
•
Protein
Organism: Mus musculus/domesticus
Length: 1528  
Fragment?: false
•
•
•
•
•
Publication
First Author: ElAli A
Year: 2010
Journal: Sci Signal
Title: Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain.
Volume: 3
Issue: 142
Pages: ra72
•
•
•
•
•
Publication
First Author: Terekhanova NV
Year: 2023
Journal: Nature
Title: Epigenetic regulation during cancer transitions across 11 tumour types.
Volume: 623
Issue: 7986
Pages: 432-441
•
•
•
•
•
Publication
First Author: F?l?p K
Year: 2011
Journal: Biochem Biophys Res Commun
Title: ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxanthoma elasticum.
Volume: 415
Issue: 3
Pages: 468-71
•
•
•
•
•
Publication  
First Author: Puris E
Year: 2024
Journal: Front Pharmacol
Title: Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.
Volume: 15
Pages: 1365051
•
•
•
•
•
Publication
First Author: Meszaros P
Year: 2013
Journal: Biochim Biophys Acta
Title: The function of the ATP-binding cassette (ABC) transporter ABCB1 is not susceptible to actin disruption.
Volume: 1828
Issue: 2
Pages: 340-51
•
•
•
•
•
Publication
First Author: Ihlefeld K
Year: 2015
Journal: J Lipid Res
Title: Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts.
Volume: 56
Issue: 1
Pages: 60-9
•
•
•
•
•
Publication
First Author: Muppidi JR
Year: 2014
Journal: Nature
Title: Loss of signalling via G?13 in germinal centre B-cell-derived lymphoma.
Volume: 516
Issue: 7530
Pages: 254-8
•
•
•
•
•
Publication
First Author: Lu E
Year: 2019
Journal: Nature
Title: S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8.
Volume: 567
Issue: 7747
Pages: 244-248
•
•
•
•
•
Publication
First Author: Bogdanov YD
Year: 1997
Journal: J Biol Chem
Title: Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos.
Volume: 272
Issue: 19
Pages: 12583-90
•
•
•
•
•
Publication
First Author: Cantagrel V
Year: 2004
Journal: J Med Genet
Title: Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males.
Volume: 41
Issue: 10
Pages: 736-42
•
•
•
•
•
Protein Domain
Type: Family
Description: This entry represents the P2Y8 receptor. It was originally identified in Xenopus and found to be activated equipotently by all naturally occurring nucleoside triphosphates (ATP, CTP, GTP, ITP and UTP) but not by inorganic polyphosphates [].P2RY8 is a G protein-coupled receptor for S-geranylgeranyl-glutathione (GGG), an endogenous metabolite present in lymphoid tissues. It couples the binding of GGG to the activation of GNA13 and downstream repression of AKT activation in lymphocytes defining their positioning and growth within lymphoid organs [, , ]. In lymphoid follicles, confines B cells and follicular helper T cells in germinal centers (GCs) in response to GGG local gradients established by GGT5 (via GGG catabolism) and ABCC1 (via extracellular transport) with lower concentrations of GGG found in the follicular dendritic cell network region around which germinal centers are formed [, , ]. In the bone marrow, also in response to GGG gradients established by GGT5 and ABCC1, it restricts chemotactic transmigration of B cells, T cells and NK cells from blood vessels to the bone marrow parenchyma [, ].There are three distinct families of extracellular receptors for purine and pyrimidine nucleotides [], known as P1, P2X and P2Y purinoceptors []. These receptors induce a wide variety of biological effects and are involved in many different cellular functions [, , ]. P2X receptors are ligand-gated ion channels, whereas P1 and P2Y receptors are rhodopsin-like G protein-coupled receptors [, ]. The families also differ by their method of activation: P1 receptors are preferentially activated by adenosine [], P2X via ATP [], whereas the P2Y receptors, in addition to being activated by ATP, are activated by different adenine and/or uridine nucleoside di- and triphosphates (ADP, UDP, UTP, UDP and UDP-glucose) [].The P2Y purinoceptors currently consist of eleven subtypes: P2Y1, P2Y2, P2Y3 P2Y4, P2Y6, P2Y8, P2Y10, P2Y11, P2Y12, P2Y13 and P2Y14 [, , ]. P2Y3 has, as yet, only been found in birds [], whilst the rest have been cloned in humans. The gaps in P2Y receptor numbering are due to the reclassification of some receptors that were initially associated with to the P2Y family. These include P2Y5 (now known as lysophosphatidic acid receptor 6), P2Y7 (now leukotriene B4 receptor) and P2Y9 (lysophosphatidic acid receptor 4) [, , , ].
•
•
•
•
•
Publication
First Author: Van Rhee AM
Year: 1995
Journal: Drug Des Discov
Title: Modelling the P2Y purinoceptor using rhodopsin as template.
Volume: 13
Issue: 2
Pages: 133-54
•
•
•
•
•
Publication
First Author: von K?gelgen I
Year: 2000
Journal: Naunyn Schmiedebergs Arch Pharmacol
Title: Molecular pharmacology of P2Y-receptors.
Volume: 362
Issue: 4-5
Pages: 310-23
•
•
•
•
•
Publication
First Author: Fern?ndez O
Year: 2000
Journal: Pharmacology
Title: Renal vascular reactivity to P(2)-purinoceptor activation in spontaneously hypertensive rats.
Volume: 60
Issue: 1
Pages: 47-50
•
•
•
•
•
Publication
First Author: Marques-da-Silva C
Year: 2011
Journal: Immunobiology
Title: Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
Volume: 216
Issue: 1-2
Pages: 1-11
•
•
•
•
•
Publication
First Author: Ferrari D
Year: 2000
Journal: FASEB J
Title: The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release.
Volume: 14
Issue: 15
Pages: 2466-76
•
•
•
•
•
Publication
First Author: Bulanova E
Year: 2010
Journal: Purinergic Signal
Title: P2 receptor-mediated signaling in mast cell biology.
Volume: 6
Issue: 1
Pages: 3-17
•
•
•
•
•
Publication
First Author: Fredholm BB
Year: 2001
Journal: Pharmacol Rev
Title: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
Volume: 53
Issue: 4
Pages: 527-52
•
•
•
•
•
Publication
First Author: von K?gelgen I
Year: 2006
Journal: Pharmacol Ther
Title: Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
Volume: 110
Issue: 3
Pages: 415-32
•
•
•
•
•
Publication
First Author: Burnstock G
Year: 1997
Journal: Neuropharmacology
Title: The past, present and future of purine nucleotides as signalling molecules.
Volume: 36
Issue: 9
Pages: 1127-39
•
•
•
•
•
Publication
First Author: Abbracchio MP
Year: 1994
Journal: Pharmacol Ther
Title: Purinoceptors: are there families of P2X and P2Y purinoceptors?
Volume: 64
Issue: 3
Pages: 445-75
•
•
•
•
•
Publication
First Author: Abbracchio MP
Year: 2006
Journal: Pharmacol Rev
Title: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.
Volume: 58
Issue: 3
Pages: 281-341
•
•
•
•
•
Publication
First Author: Webb TE
Year: 1993
Journal: FEBS Lett
Title: Cloning and functional expression of a brain G-protein-coupled ATP receptor.
Volume: 324
Issue: 2
Pages: 219-25
•
•
•
•
•
Publication
First Author: Yanagida K
Year: 2009
Journal: J Biol Chem
Title: Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
Volume: 284
Issue: 26
Pages: 17731-41
•
•
•
•
•
Publication
First Author: Owman C
Year: 1996
Journal: Genomics
Title: Cloning of cDNA encoding a putative chemoattractant receptor.
Volume: 37
Issue: 2
Pages: 187-94
•
•
•
•
•
Publication
First Author: Akbar GK
Year: 1996
Journal: J Biol Chem
Title: Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells.
Volume: 271
Issue: 31
Pages: 18363-7
•
•
•
•
•
Publication
First Author: Noguchi K
Year: 2003
Journal: J Biol Chem
Title: Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Volume: 278
Issue: 28
Pages: 25600-6
•
•
•
•
•
Publication
First Author: Van Kolen K
Year: 2006
Journal: Purinergic Signal
Title: Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.
Volume: 2
Issue: 3
Pages: 451-69
•
•
•
•
•
Publication
First Author: Ralevic V
Year: 1998
Journal: Pharmacol Rev
Title: Receptors for purines and pyrimidines.
Volume: 50
Issue: 3
Pages: 413-92
•
•
•
•
•
Publication
First Author: Gachet C
Year: 2001
Journal: Int J Hematol
Title: Identification, characterization, and inhibition of the platelet ADP receptors.
Volume: 74
Issue: 4
Pages: 375-81
•
•
•
•
•
Publication
First Author: Montiel M
Year: 2006
Journal: Cell Physiol Biochem
Title: P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells.
Volume: 18
Issue: 1-3
Pages: 123-34
•
•
•
•
•
Publication
First Author: Wood JD
Year: 2006
Journal: Curr Opin Pharmacol
Title: The enteric purinergic P2Y1 receptor.
Volume: 6
Issue: 6
Pages: 564-70
•
•
•
•
•
Publication
First Author: Adrian K
Year: 2000
Journal: Biochim Biophys Acta
Title: Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells.
Volume: 1492
Issue: 1
Pages: 127-38
•
•
•
•
•
Publication
First Author: North RA
Year: 2002
Journal: Physiol Rev
Title: Molecular physiology of P2X receptors.
Volume: 82
Issue: 4
Pages: 1013-67
•
•
•
•
•